Serra-Prat M, Gallo P, Jovell A J, Aymerich M, Estrada M D
Catalan Agency for Health Technology Assessment, Generalitat de Catalunya, Barcelona, Spain.
Am J Public Health. 1998 Apr;88(4):551-7. doi: 10.2105/ajph.88.4.551.
This paper presents the results of different screening policies for prenatal detection of Down syndrome that would allow decision makers to make informed choices.
A decision analysis model was built to compare 8 screening policies with regard to a selected set of outcome measures. Probabilities used in the analysis were obtained from official administrative data reports in Spain and Catalonia and from data published in the medical literature. Sensitivity analyses were carried out to test the robustness of screening policies' results to changes in uptake rates, diagnostic accuracy, and resources consumed.
Selected screening policies posed major trades-offs regarding detection rates, false-positive results, fetal loss, and costs of the programs. All outcome measures considered were found quite robust to changes in uptake rates. Sensitivity and specificity rates of screening tests were shown to be the most influential factors in the outcome measures considered.
The disclosed trade-offs emphasize the need to comprehensively inform decision makers about both positive and negative consequences of adopting one screening policy or another.
本文展示了用于唐氏综合征产前检测的不同筛查策略的结果,以便决策者做出明智的选择。
构建了一个决策分析模型,以比较8种筛查策略在一组选定的结果指标方面的情况。分析中使用的概率来自西班牙和加泰罗尼亚的官方行政数据报告以及医学文献中发表的数据。进行了敏感性分析,以测试筛查策略结果对接受率、诊断准确性和资源消耗变化的稳健性。
选定的筛查策略在检测率、假阳性结果、胎儿丢失和项目成本方面存在重大权衡。所有考虑的结果指标对接受率的变化都相当稳健。筛查试验的敏感性和特异性率被证明是所考虑的结果指标中最具影响力的因素。
所揭示的权衡强调了需要全面告知决策者采用一种或另一种筛查策略的正面和负面后果。